TheEdgeResearch
Home / Stocks / KRSNAA.NS

Krsnaa Diagnostics Limited (KRSNAA.NS)

NSE Healthcare Medical - Diagnostics & Research
$575.30 ▲ +3.33%
Market Cap
$18.66B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.06
52-Wk Range
515-894.4
CEO
Mitesh Dave
Country
IN
Currency
INR

Krsnaa Diagnostics Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Pune, MA, IN. The stock last traded at $575.30, up 3.33% on the session, giving a market capitalisation of $18.66B. Its beta of 0.06 implies it has historically moved less than the broad market.

Company profile
Exchange
National Stock Exchange of India
Employees
3,700
IPO date
2021-08-16
Headquarters
Pune, MA, IN
About Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited specializes in delivering a comprehensive range of diagnostic solutions. The company utilizes technology to provide services such as radiology, clinical pathology, and tele-radiology to diverse clients, including public and private healthcare facilities, medical colleges, and local community health centers. By December 31, 2020, its extensive network featured 1,801 diagnostic centers distributed across 13 Indian states. Established in 2010, the company maintains its headquarters in Pune, India.

Comparable companies

Krsnaa Diagnostics Limited is most often compared with the following Healthcare names:

DRAGARWQ.BOIOLCP.BOIOLCP.NSSMSPHARMA.BOSMSPHARMA.NSVIMTALABS.BOVIMTALABS.NS
More research on KRSNAA.NS
KRSNAA.NS technical analysis KRSNAA.NS TheEdge Score Compare against peers
Open full interactive analysis & DCF →